2014.03.31 Form 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________________________________
FORM 10-Q
____________________________________________
(Mark One)
|
| |
[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2014
OR
|
| |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
____________________________________________
Commission file number: 001-31826
____________________________________________
CENTENE CORPORATION
(Exact name of registrant as specified in its charter)
|
| |
Delaware | 42-1406317 |
(State or other jurisdiction of | (I.R.S. Employer |
incorporation or organization) | Identification Number) |
| |
7700 Forsyth Boulevard | |
St. Louis, Missouri | 63105 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:
(314) 725-4477
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: x Yes o No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer x Accelerated filer o Non-accelerated filer o (do not check if a smaller reporting company) Smaller reporting company o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x
As of April 11, 2014, the registrant had 57,680,118 shares of common stock outstanding.
CENTENE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
|
| | |
| | PAGE |
| | |
| Part I | |
| Financial Information | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
| Part II | |
| Other Information | |
Item 1. | | |
Item 1A. | | |
Item 2. | | |
Item 6. | | |
| | |
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. We have attempted to identify these statements by terminology including “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “seek,” “target,” “goal,” “may,” “will,” “should,” “can,” “continue” and other similar words or expressions in connection with, among other things, any discussion of future operating or financial performance. In particular, these statements include statements about our market opportunity, our growth strategy, competition, expected activities and future acquisitions, investments and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, including those entitled “Management's Discussion and Analysis of Financial Condition and Results of Operations,” Part II, Item 1A. “Risk Factors,” and Part II, Item I “Legal Proceedings.” Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions.
All forward-looking statements included in this filing are based on information available to us on the date of this filing and we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events or otherwise, after the date of this filing. Actual results may differ from projections or estimates due to a variety of important factors, including:
| |
• | our ability to accurately predict and effectively manage health benefits and other operating expenses; |
| |
• | membership and revenue projections; |
| |
• | timing of regulatory contract approval; |
| |
• | changes in healthcare practices; |
| |
• | changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder; |
| |
• | changes in expected contract start dates; |
| |
• | changes in expected closing dates and accretion for acquisitions; |
| |
• | provider and state contract changes; |
| |
• | reduction in provider payments by governmental payors; |
| |
• | disasters and numerous other factors affecting the delivery and cost of healthcare; |
| |
• | the expiration, cancellation or suspension of our Medicare or Medicaid managed care contracts by federal or state governments; |
| |
• | the outcome of pending legal proceedings; |
| |
• | availability of debt and equity financing, on terms that are favorable to us; and |
| |
• | general economic and market conditions. |
Other Information
The discussion in Part I, Item 2. "Management’s Discussion and Analysis of Financial Condition and Results of Operations" under the heading "Results of Operations" contains financial information for new and existing businesses. Existing businesses are primarily state markets, significant geographic expansion in an existing state or product that we have managed for four complete quarters. New businesses are primarily new state markets, significant geographic expansion in an existing state or product that conversely, we have not managed for four complete quarters.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing individuals to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
PART I
FINANCIAL INFORMATION
ITEM 1. Financial Statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
|
| | | | | | | |
| March 31, 2014 | | December 31, 2013 |
ASSETS | | | |
Current assets: | | | |
Cash and cash equivalents of continuing operations | $ | 1,218,004 |
| | $ | 974,304 |
|
Cash and cash equivalents of discontinued operations | 52,788 |
| | 63,769 |
|
Total cash and cash equivalents | 1,270,792 |
| | 1,038,073 |
|
Premium and related receivables | 570,105 |
| | 428,570 |
|
Short term investments | 99,696 |
| | 102,126 |
|
Other current assets | 320,393 |
| | 217,661 |
|
Other current assets of discontinued operations | 20,863 |
| | 13,743 |
|
Total current assets | 2,281,849 |
| | 1,800,173 |
|
Long term investments | 840,152 |
| | 791,900 |
|
Restricted deposits | 57,826 |
| | 46,946 |
|
Property, software and equipment, net | 412,699 |
| | 395,407 |
|
Goodwill | 657,551 |
| | 348,432 |
|
Intangible assets, net | 85,134 |
| | 48,780 |
|
Other long term assets | 80,961 |
| | 59,357 |
|
Long term assets of discontinued operations | 30,275 |
| | 38,305 |
|
Total assets | $ | 4,446,447 |
| | $ | 3,529,300 |
|
| | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | |
|
Current liabilities: | |
| | |
|
Medical claims liability | $ | 1,298,513 |
| | $ | 1,111,709 |
|
Accounts payable and accrued expenses | 614,541 |
| | 375,862 |
|
Unearned revenue | 74,260 |
| | 38,191 |
|
Current portion of long term debt | 6,110 |
| | 3,065 |
|
Current liabilities of discontinued operations | 28,019 |
| | 30,294 |
|
Total current liabilities | 2,021,443 |
| | 1,559,121 |
|
Long term debt | 810,970 |
| | 665,697 |
|
Other long term liabilities | 70,166 |
| | 60,015 |
|
Long term liabilities of discontinued operations | 1,009 |
| | 1,028 |
|
Total liabilities | 2,903,588 |
| | 2,285,861 |
|
Commitments and contingencies |
|
| |
|
|
Redeemable noncontrolling interest | 120,681 |
| | — |
|
Stockholders’ equity: | |
| | |
|
Common stock, $.001 par value; authorized 100,000,000 shares; 61,044,175 issued and 57,657,040 outstanding at March 31, 2014, and 58,673,215 issued and 55,319,239 outstanding at December 31, 2013 | 61 |
| | 59 |
|
Additional paid-in capital | 739,972 |
| | 594,326 |
|
Accumulated other comprehensive income: | | | |
Unrealized loss on investments, net of tax | (614 | ) | | (2,620 | ) |
Retained earnings | 764,902 |
| | 731,919 |
|
Treasury stock, at cost (3,387,135 and 3,353,976 shares, respectively) | (91,655 | ) | | (89,643 | ) |
Total Centene stockholders’ equity | 1,412,666 |
| | 1,234,041 |
|
Noncontrolling interest | 9,512 |
| | 9,398 |
|
Total stockholders’ equity | 1,422,178 |
| | 1,243,439 |
|
Total liabilities and stockholders’ equity | $ | 4,446,447 |
| | $ | 3,529,300 |
|
The accompanying notes to the consolidated financial statements are an integral part of these statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)
(Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 |
Revenues: | | | |
Premium | $ | 3,070,887 |
| | $ | 2,388,639 |
|
Service | 281,174 |
| | 33,194 |
|
Premium and service revenues | 3,352,061 |
| | 2,421,833 |
|
Premium tax and health insurer fee | 107,827 |
| | 103,649 |
|
Total revenues | 3,459,888 |
| | 2,525,482 |
|
Expenses: | | | |
Medical costs | 2,742,453 |
| | 2,154,546 |
|
Cost of services | 242,284 |
| | 25,065 |
|
General and administrative expenses | 295,512 |
| | 203,296 |
|
Premium tax expense | 78,278 |
| | 102,975 |
|
Health insurer fee expense | 31,327 |
| | — |
|
Total operating expenses | 3,389,854 |
| | 2,485,882 |
|
Earnings from operations | 70,034 |
| | 39,600 |
|
Other income (expense): | | | |
Investment and other income | 4,724 |
| | 4,263 |
|
Interest expense | (7,023 | ) | | (6,625 | ) |
Earnings from continuing operations, before income tax expense | 67,735 |
| | 37,238 |
|
Income tax expense | 34,555 |
| | 14,690 |
|
Earnings from continuing operations, net of income tax expense | 33,180 |
| | 22,548 |
|
Discontinued operations, net of income tax expense (benefit) of $(8),and $348, respectively | (833 | ) | | 363 |
|
Net earnings | 32,347 |
| | 22,911 |
|
Noncontrolling interest | (636 | ) | | (91 | ) |
Net earnings attributable to Centene Corporation | $ | 32,983 |
| | $ | 23,002 |
|
| | | |
Amounts attributable to Centene Corporation common shareholders: | | | |
Earnings from continuing operations, net of income tax expense | $ | 33,816 |
| | $ | 22,639 |
|
Discontinued operations, net of income tax expense (benefit) | (833 | ) | | 363 |
|
Net earnings | $ | 32,983 |
| | $ | 23,002 |
|
| | | |
Net earnings (loss) per common share attributable to Centene Corporation: |
Basic: | | | |
Continuing operations | $ | 0.59 |
| | $ | 0.43 |
|
Discontinued operations | (0.02 | ) | | 0.01 |
|
Basic earnings per common share | $ | 0.57 |
| | $ | 0.44 |
|
| | | |
Diluted: | | | |
Continuing operations | $ | 0.57 |
| | $ | 0.41 |
|
Discontinued operations | (0.01 | ) | | 0.01 |
|
Diluted earnings per common share | $ | 0.56 |
| | $ | 0.42 |
|
| | | |
Weighted average number of common shares outstanding: |
Basic | 57,483,876 |
| | 52,357,119 |
|
Diluted | 59,361,266 |
| | 54,266,928 |
|
The accompanying notes to the consolidated financial statements are an integral part of these statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF COMPREHENSIVE EARNINGS
(In thousands)
(Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 |
Net earnings | $ | 32,347 |
| | $ | 22,911 |
|
Reclassification adjustment, net of tax | (45 | ) | | (29 | ) |
Change in unrealized loss on investments, net of tax | 2,051 |
| | (260 | ) |
Other comprehensive earnings | 2,006 |
| | (289 | ) |
Comprehensive earnings | 34,353 |
| | 22,622 |
|
Comprehensive earnings attributable to the noncontrolling interest | (636 | ) | | (91 | ) |
Comprehensive earnings attributable to Centene Corporation | $ | 34,989 |
| | $ | 22,713 |
|
The accompanying notes to the consolidated financial statements are an integral part of this statement.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
(In thousands, except share data)
(Unaudited)
Three Months Ended March 31, 2014
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Centene Stockholders’ Equity | | | | |
| Common Stock | | | | | | | | Treasury Stock | | | | |
| $.001 Par Value Shares | | Amt | | Additional Paid-in Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | $.001 Par Value Shares | | Amt | | Non controlling Interest | | Total |
Balance, December 31, 2013 | 58,673,215 |
| | $ | 59 |
| | $ | 594,326 |
| | $ | (2,620 | ) | | $ | 731,919 |
| | 3,353,976 |
| | $ | (89,643 | ) | | $ | 9,398 |
| | $ | 1,243,439 |
|
Comprehensive Earnings: | | | | | | | | | | | | | | | | | |
Net earnings | — |
| | — |
| | — |
| | — |
| | 32,983 |
| | — |
| | — |
| | 114 |
| | 33,097 |
|
Change in unrealized investment loss, net of $1,129 tax | — |
| | — |
| | — |
| | 2,006 |
| | — |
| | — |
| | — |
| | — |
| | 2,006 |
|
Total comprehensive earnings | | | | | | | | | |
| | | | | | | | 35,103 |
|
Common stock issued for acquisition | 2,243,217 |
| | 2 |
| | 132,369 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 132,371 |
|
Common stock issued for employee benefit plans | 127,743 |
| | — |
| | 1,668 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 1,668 |
|
Common stock repurchases | — |
| | — |
| | — |
| | — |
| | — |
| | 33,159 |
| | (2,012 | ) | | — |
| | (2,012 | ) |
Stock compensation expense | — |
| | — |
| | 11,297 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 11,297 |
|
Excess tax benefits from stock compensation | — |
| | — |
| | 312 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 312 |
|
Balance, March 31, 2014 | 61,044,175 |
| | $ | 61 |
| | $ | 739,972 |
| | $ | (614 | ) | | $ | 764,902 |
| | 3,387,135 |
| | $ | (91,655 | ) | | $ | 9,512 |
| | $ | 1,422,178 |
|
The accompanying notes to the consolidated financial statements are an integral part of this statement.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 |
Cash flows from operating activities: | | | |
Net earnings | $ | 32,347 |
| | $ | 22,911 |
|
Adjustments to reconcile net earnings to net cash provided by operating activities |
Depreciation and amortization | 20,318 |
| | 15,691 |
|
Stock compensation expense | 11,297 |
| | 8,375 |
|
Deferred income taxes | (7,873 | ) | | 986 |
|
Changes in assets and liabilities | |
| | |
|
Premium and related receivables | (119,207 | ) | | (56,734 | ) |
Other current assets | 3,411 |
| | (50,537 | ) |
Other assets | (14,425 | ) | | 5 |
|
Medical claims liabilities | 196,221 |
| | 117,385 |
|
Unearned revenue | 34,662 |
| | 3,578 |
|
Accounts payable and accrued expenses | 90,481 |
| | (22,745 | ) |
Other operating activities | 5,213 |
| | 4,078 |
|
Net cash provided by operating activities | 252,445 |
| | 42,993 |
|
Cash flows from investing activities: | |
| | |
|
Capital expenditures | (18,116 | ) | | (10,654 | ) |
Purchases of investments | (167,373 | ) | | (358,131 | ) |
Sales and maturities of investments | 111,994 |
| | 212,508 |
|
Investments in acquisitions, net of cash acquired | (76,989 | ) | | — |
|
Net cash used in investing activities | (150,484 | ) | | (156,277 | ) |
Cash flows from financing activities: | |
| | |
|
Proceeds from exercise of stock options | 1,464 |
| | 1,408 |
|
Proceeds from borrowings | 645,000 |
| | — |
|
Payment of long-term debt | (519,413 | ) | | (776 | ) |
Excess tax benefits from stock compensation | 312 |
| | 515 |
|
Common stock repurchases | (2,012 | ) | | (565 | ) |
Contribution from noncontrolling interest | 5,407 |
| | 202 |
|
Debt issue costs | — |
| | (661 | ) |
Net cash provided by financing activities | 130,758 |
| | 123 |
|
Net increase (decrease) in cash and cash equivalents | 232,719 |
| | (113,161 | ) |
Cash and cash equivalents, beginning of period | 1,038,073 |
| | 843,952 |
|
Cash and cash equivalents, end of period | $ | 1,270,792 |
| | $ | 730,791 |
|
Supplemental disclosures of cash flow information: | |
| | |
|
Interest paid | $ | 1,648 |
| | $ | 1,410 |
|
Income taxes paid | 21,265 |
| | 2,205 |
|
Equity issued in connection with acquisition | 132,371 |
| | — |
|
The accompanying notes to the consolidated financial statements are an integral part of these statements.
CENTENE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except share data)
(Unaudited)
1. Basis of Presentation
The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2013. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures which would substantially duplicate the disclosures contained in the December 31, 2013 audited financial statements have been omitted from these interim financial statements where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.
Certain 2013 amounts in the notes to the consolidated financial statements have been reclassified to conform to the 2014 presentation. These reclassifications have no effect on net earnings or stockholders’ equity as previously reported.
2. Acquisition: U.S. Medical Management
In January 2014, the Company acquired 68% of U.S. Medical Management, LLC (USMM), a management services organization and provider of in-home health services for high acuity populations, for $214,907 in total consideration. The transaction consideration was financed through a combination of $132,686 of Centene common stock and $82,221 of cash.
The Company's preliminary allocation of fair value resulted in goodwill of $309,014 and other identifiable intangible assets of $40,170. Approximately 70% of the goodwill is deductible for income tax purposes. The Company has not finalized the allocation of the fair value of assets and liabilities. The acquisition is recorded in the Specialty Services segment.
In connection with the acquisition, the Company entered into call and put agreements with the noncontrolling interest holder to purchase the noncontrolling interest at a later date. Under these agreements, the Company may purchase or be required to purchase up to the total remaining interests in USMM over a period beginning in 2015 and continuing through 2017. Under certain circumstances, the agreements may be extended through 2020. At the Company’s sole option, up to 50% of the consideration to be issued for the purchase of the additional interests under these agreements may be funded with shares of the Company's common stock.
As a result of the put option agreement, the noncontrolling interest is considered redeemable and is classified in the Redeemable Noncontrolling Interest section of our consolidated balance sheet. The noncontrolling interest was initially measured at fair value using the binomial lattice mode as of the acquisition date. The Company has elected to accrete changes in the redemption value through additional paid-in capital over the period from the date of issuance to the earliest redemption date following the effective interest method.
A reconciliation of the changes in the Redeemable Noncontrolling Interest is as follows:
|
| | | | |
Balance, December 31, 2013 | | $ | — |
|
Fair value of noncontrolling interest at acquisition | | 116,024 |
|
Contribution from noncontrolling interest | | 5,407 |
|
Net earnings attributable to noncontrolling interest | | (750 | ) |
Balance, March 31, 2014 | | $ | 120,681 |
|
3. Discontinued Operations: Kentucky Spirit Health Plan
In October 2012, the Company notified the Kentucky Cabinet for Health and Family Services (Cabinet) that it was exercising a contractual right that it believes allows the Company to terminate its Medicaid managed care contract with the Commonwealth of Kentucky (Commonwealth) effective July 5, 2013. As of July 6, 2013, our subsidiary, Kentucky Spirit Health Plan (KSHP), ceased serving Medicaid members in Kentucky. Accordingly, the results of operations of KSHP are presented as discontinued operations for all periods presented. The assets, liabilities and results of operations of KSHP are classified as discontinued operations for all periods presented beginning in 2011. KSHP was previously reported in the Managed Care segment.
During the three months ended March 31, 2014, the Company received $8,000 of dividends from KSHP. KSHP had remaining statutory capital of approximately $71,500 at March 31, 2014, which, subject to future dividends, will be transferred to unregulated cash upon regulatory approval.
Operating results for the discontinued operations are as follows:
|
| | | | | | | | |
| | Three Months Ended March 31, |
| | 2014 | | 2013 |
Revenues | | $ | — |
| | $ | 120,410 |
|
Earnings (loss) before income taxes | | $ | (841 | ) | | $ | 711 |
|
Net earnings (loss) | | $ | (833 | ) | | $ | 363 |
|
The net loss from discontinued operations for the three months ended March 31, 2014 includes $894 of health insurer fee expense based on 2013 premium.
Assets and liabilities of the discontinued operations are as follows:
|
| | | | | | | | | |
| | March 31, 2014 | | December 31, 2013 | |
Current assets | | $ | 73,651 |
| | $ | 77,512 |
| |
Long term investments and restricted deposits | | 30,275 |
| | 38,305 |
| |
Assets of discontinued operations | | $ | 103,926 |
| | $ | 115,817 |
| |
| | | | | |
Medical claims liability | | $ | 21,939 |
| | $ | 27,637 |
| |
Accounts payable and accrued expenses | | 6,080 |
| | 2,657 |
| |
Other liabilities | | 1,009 |
| | 1,028 |
| |
Liabilities of discontinued operations | | $ | 29,028 |
| | $ | 31,322 |
| |
4. Short-term and Long-term Investments and Restricted Deposits
Short-term and long-term investments and restricted deposits by investment type consist of the following:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | December 31, 2013 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | 280,182 |
| | $ | 215 |
| | $ | (5,711 | ) | | $ | 274,686 |
| | $ | 246,085 |
| | $ | 245 |
| | $ | (7,494 | ) | | $ | 238,836 |
|
Corporate securities | 305,315 |
| | 3,367 |
| | (150 | ) | | 308,532 |
| | 293,912 |
| | 2,782 |
| | (608 | ) | | 296,086 |
|
Restricted certificates of deposit | 5,892 |
| | — |
| | — |
| | 5,892 |
| | 5,891 |
| | — |
| | — |
| | 5,891 |
|
Restricted cash equivalents | 37,516 |
| | — |
| | — |
| | 37,516 |
| | 26,642 |
| | — |
| | — |
| | 26,642 |
|
Municipal securities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
General obligation | 45,283 |
| | 492 |
| | (150 | ) | | 45,625 |
| | 54,003 |
| | 555 |
| | (136 | ) | | 54,422 |
|
Pre-refunded | 6,409 |
| | 40 |
| | (4 | ) | | 6,445 |
| | 10,835 |
| | 82 |
| | — |
| | 10,917 |
|
Revenue | 65,728 |
| | 515 |
| | (133 | ) | | 66,110 |
| | 68,801 |
| | 545 |
| | (292 | ) | | 69,054 |
|
Variable rate demand notes | 14,030 |
| | — |
| | — |
| | 14,030 |
| | 28,575 |
| | — |
| | — |
| | 28,575 |
|
Asset backed securities | 150,717 |
| | 583 |
| | (282 | ) | | 151,018 |
| | 138,803 |
| | 579 |
| | (332 | ) | | 139,050 |
|
Mortgage backed securities | 48,284 |
| | 369 |
| | — |
| | 48,653 |
| | 33,974 |
| | — |
| | (83 | ) | | 33,891 |
|
Cost and equity method investments | 23,716 |
| | — |
| | — |
| | 23,716 |
| | 22,239 |
| | — |
| | — |
| | 22,239 |
|
Life insurance contracts | 15,451 |
| | — |
| | — |
| | 15,451 |
| | 15,369 |
| | — |
| | — |
| | 15,369 |
|
Total | $ | 998,523 |
| | $ | 5,581 |
| | $ | (6,430 | ) | | $ | 997,674 |
| | $ | 945,129 |
| | $ | 4,788 |
| | $ | (8,945 | ) | | $ | 940,972 |
|
The Company’s investments are classified as available-for-sale with the exception of life insurance contracts and certain cost and equity method investments. The Company’s investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. The Company's mortgage backed securities are issued by the Federal National Mortgage Association and carry guarantees by the U.S. government. As of March 31, 2014, 55% of the Company’s investments in securities recorded at fair value that carry a rating by S&P or Moody’s were rated AAA/Aaa, 69% were rated AA-/Aa3 or higher, and 93% were rated A-/A3 or higher. At March 31, 2014, the Company held certificates of deposit, life insurance contracts and cost and equity method investments which did not carry a credit rating.
The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | December 31, 2013 |
| Less Than 12 Months | | 12 Months or More | | Less Than 12 Months | | 12 Months or More |
| Unrealized Losses | | Fair Value | | Unrealized Losses | | Fair Value | | Unrealized Losses | | Fair Value | | Unrealized Losses | | Fair Value |
U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | (4,665 | ) | | $ | 188,344 |
| | $ | (1,046 | ) | | $ | 26,547 |
| | $ | (6,188 | ) | | $ | 172,365 |
| | $ | (1,307 | ) | | $ | 26,454 |
|
Corporate securities | (116 | ) | | 24,091 |
| | (34 | ) | | 5,185 |
| | (400 | ) | | 52,725 |
| | (207 | ) | | 5,020 |
|
Municipal securities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
General obligation | (73 | ) | | 3,452 |
| | (77 | ) | | 2,398 |
| | (72 | ) | | 3,480 |
| | (63 | ) | | 2,426 |
|
Pre-refunded | (4 | ) | | 1,047 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
Revenue | (43 | ) | | 11,539 |
| | (90 | ) | | 3,391 |
| | (292 | ) | | 27,789 |
| | — |
| | — |
|
Asset backed securities | (282 | ) | | 45,121 |
| | — |
| | — |
| | (333 | ) | | 37,689 |
| | — |
| | — |
|
Mortgage backed securities | — |
| | — |
| | — |
| | — |
| | (83 | ) | | 33,891 |
| | — |
| | — |
|
Total | $ | (5,183 | ) | | $ | 273,594 |
| | $ | (1,247 | ) | | $ | 37,521 |
| | $ | (7,368 | ) | | $ | 327,939 |
| | $ | (1,577 | ) | | $ | 33,900 |
|
As of March 31, 2014, the gross unrealized losses were generated from 64 positions out of a total of 327 positions. The change in fair value of fixed income securities is a result of movement in interest rates subsequent to the purchase of the security.
For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If the security meets this criterion, the decline in fair value is other-than-temporary and is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, there is no indication of other than temporary impairment for these securities.
The contractual maturities of short-term and long-term investments and restricted deposits are as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | December 31, 2013 |
| Investments | | Restricted Deposits | | Investments | | Restricted Deposits |
| Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value |
One year or less | $ | 99,194 |
| | $ | 99,696 |
| | $ | 47,398 |
| | $ | 47,400 |
| | $ | 101,537 |
| | $ | 102,126 |
| | $ | 40,633 |
| | $ | 40,637 |
|
One year through five years | 680,134 |
| | 682,289 |
| | 10,412 |
| | 10,426 |
| | 609,755 |
| | 610,589 |
| | 6,301 |
| | 6,309 |
|
Five years through ten years | 144,676 |
| | 140,756 |
| | — |
| | — |
| | 157,003 |
| | 151,221 |
| | — |
| | — |
|
Greater than ten years | 16,709 |
| | 17,107 |
| | — |
| | — |
| | 29,900 |
| | 30,090 |
| | — |
| | — |
|
Total | $ | 940,713 |
| | $ | 939,848 |
| | $ | 57,810 |
| | $ | 57,826 |
| | $ | 898,195 |
| | $ | 894,026 |
| | $ | 46,934 |
| | $ | 46,946 |
|
Actual maturities may differ from contractual maturities due to call or prepayment options. Asset backed and mortgage backed securities are included in the one year through five years category, while cost and equity method investments and life insurance contracts are included in the five years through ten years category. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.
The Company continuously monitors investments for other-than-temporary impairment. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an impairment loss for cost and equity method investments when evidence demonstrates that it is other-than-temporarily impaired. Evidence of a loss in value that is other-than-temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.
5. Fair Value Measurements
Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon the extent to which the fair value estimates are based upon observable or unobservable inputs. Level inputs are as follows:
|
| | |
Level Input: | | Input Definition: |
Level I | | Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. |
| | |
Level II | | Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date. |
| | |
Level III | | Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. |
The following table summarizes fair value measurements by level at March 31, 2014, for assets and liabilities measured at fair value on a recurring basis:
|
| | | | | | | | | | | | | | | |
| Level I | | Level II | | Level III | | Total |
Assets | | | | | | | |
Cash and cash equivalents | $ | 1,218,004 |
| | $ | — |
| | $ | — |
| | $ | 1,218,004 |
|
Investments available for sale: | |
| | |
| | |
| | |
|
U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | 243,022 |
| | $ | 17,246 |
| | $ | — |
| | $ | 260,268 |
|
Corporate securities | — |
| | 308,532 |
| | — |
| | 308,532 |
|
Municipal securities: | |
| | |
| | |
| | |
General obligation | — |
| | 45,625 |
| | — |
| | 45,625 |
|
Pre-refunded | — |
| | 6,445 |
| | — |
| | 6,445 |
|
Revenue | — |
| | 66,110 |
| | — |
| | 66,110 |
|
Variable rate demand notes | — |
| | 14,030 |
| | — |
| | 14,030 |
|
Asset backed securities | — |
| | 151,018 |
| | — |
| | 151,018 |
|
Mortgage backed securities | — |
| | 48,653 |
| | — |
| | 48,653 |
|
Total investments | $ | 243,022 |
| | $ | 657,659 |
| | $ | — |
| | $ | 900,681 |
|
Restricted deposits available for sale: | |
| | |
| | |
| | |
|
Cash and cash equivalents | $ | 37,516 |
| | $ | — |
| | $ | — |
| | $ | 37,516 |
|
Certificates of deposit | 5,892 |
| | — |
| | — |
| | 5,892 |
|
U.S. Treasury securities and obligations of U.S. government corporations and agencies | 14,418 |
| | — |
| | — |
| | 14,418 |
|
Total restricted deposits | $ | 57,826 |
| | $ | — |
| | $ | — |
| | $ | 57,826 |
|
Other long-term assets: Interest rate swap contract | $ | — |
| | $ | 8,638 |
| | $ | — |
| | $ | 8,638 |
|
Total assets at fair value | $ | 1,518,852 |
| | $ | 666,297 |
| | $ | — |
| | $ | 2,185,149 |
|
The following table summarizes fair value measurements by level at December 31, 2013, for assets and liabilities measured at fair value on a recurring basis:
|
| | | | | | | | | | | | | | | |
| Level I | | Level II | | Level III | | Total |
Assets | | | | | | | |
Cash and cash equivalents | $ | 974,304 |
| | $ | — |
| | $ | — |
| | $ | 974,304 |
|
Investments available for sale: | |
| | |
| | |
| | |
|
U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | 212,185 |
| | $ | 12,238 |
| | $ | — |
| | $ | 224,423 |
|
Corporate securities | — |
| | 296,086 |
| | — |
| | 296,086 |
|
Municipal securities: | |
| | |
| | |
| | |
General obligation | — |
| | 54,422 |
| | — |
| | 54,422 |
|
Pre-refunded | — |
| | 10,917 |
| | — |
| | 10,917 |
|
Revenue | — |
| | 69,054 |
| | — |
| | 69,054 |
|
Variable rate demand notes | — |
| | 28,575 |
| | — |
| | 28,575 |
|
Asset backed securities | — |
| | 139,050 |
| | — |
| | 139,050 |
|
Mortgage backed securities | — |
| | 33,891 |
| | — |
| | 33,891 |
|
Total investments | $ | 212,185 |
| | $ | 644,233 |
| | $ | — |
| | $ | 856,418 |
|
Restricted deposits available for sale: | |
| | |
| | |
| | |
|
Cash and cash equivalents | $ | 26,642 |
| | $ | — |
| | $ | — |
| | $ | 26,642 |
|
Certificates of deposit | 5,891 |
| | — |
| | — |
| | 5,891 |
|
U.S. Treasury securities and obligations of U.S. government corporations and agencies | 14,413 |
| | — |
| | — |
| | 14,413 |
|
Total restricted deposits | $ | 46,946 |
| | $ | — |
| | $ | — |
| | $ | 46,946 |
|
Other long-term assets: Interest rate swap contract | $ | — |
| | $ | 9,576 |
| | $ | — |
| | $ | 9,576 |
|
Total assets at fair value | $ | 1,233,435 |
| | $ | 653,809 |
| | $ | — |
| | $ | 1,887,244 |
|
The Company periodically transfers U.S. Treasury securities and obligations of U.S. government corporations and agencies between Level I and Level II fair value measurements dependent upon the level of trading activity for the specific securities at the measurement date. The Company’s policy regarding the timing of transfers between Level I and Level II is to measure and record the transfers at the end of the reporting period. At March 31, 2014, there were $13,765 transfers from Level I to Level II and $1,737 of transfers from Level II to Level I. The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. The aggregate carrying amount of the Company’s life insurance contracts and other non-majority owned investments, which approximates fair value, was $39,167 and $37,608 as of March 31, 2014 and December 31, 2013, respectively.
6. Debt
Debt consists of the following:
|
| | | | | | | |
| March 31, 2014 | | December 31, 2013 |
Senior notes, at par | $ | 425,000 |
| | $ | 425,000 |
|
Unamortized premium on senior notes | 5,609 |
| | 6,052 |
|
Interest rate swap fair value | 8,638 |
| | 9,576 |
|
Senior notes | 439,247 |
| | 440,628 |
|
Revolving credit agreement | 295,000 |
| | 150,000 |
|
Mortgage notes payable | 72,115 |
| | 72,785 |
|
Capital leases and other | 10,718 |
| | 5,349 |
|
Total debt | 817,080 |
| | 668,762 |
|
Less current portion | (6,110 | ) | | (3,065 | ) |
Long-term debt | $ | 810,970 |
| | $ | 665,697 |
|
Senior Notes
In May 2011, the Company issued $250,000 non-callable 5.75% Senior Notes due June 1, 2017 (the $250,000 Notes) at a discount to yield 6%. In connection with the May 2011 issuance, the Company entered into an interest rate swap for a notional amount of $250,000. Gains and losses due to changes in the fair value of the interest rate swap completely offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $250,000 Notes. At March 31, 2014, the fair value of the interest rate swap increased the fair value of the notes by $8,638 and the variable interest rate of the swap was 3.74%.
In November 2012, the Company issued an additional $175,000 non-callable 5.75% Senior Notes due June 1, 2017 ($175,000 Add-on Notes) at a premium to yield 4.29%. The indenture governing the $250,000 Notes and the $175,000 Add-on Notes contains non-financial and financial covenants, including requirements of a minimum fixed charge coverage ratio. Interest is paid semi-annually in June and December. At March 31, 2014, the total net unamortized debt premium on the $250,000 Notes and $175,000 Add-on Notes was $5,609.
Revolving Credit Agreement
In May 2013, the Company entered into a new unsecured $500,000 revolving credit facility and terminated its previous $350,000 revolving credit facility. Borrowings under the agreement bear interest based upon LIBOR rates, the Federal Funds Rate or the Prime Rate. The agreement has a maturity date of June 1, 2018, provided it will mature 90 days prior to the maturity date of the Company's 5.75% Senior Notes due 2017 if such notes are not refinanced (or extended), certain financial conditions are not met, or the Company does not carry $100,000 of unrestricted cash. As of March 31, 2014, the Company had $295,000 borrowings outstanding under the agreement with a weighted average interest rate of 2.58%.
The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0. As of March 31, 2014, there were no limitations on the availability under the revolving credit agreement as a result of the debt-to-EBITDA ratio.
Letters of Credit & Surety Bonds
The Company had outstanding letters of credit of $28,757 as of March 31, 2014, which were not part of the revolving credit facility. The letters of credit bore interest at 0.47% as of March 31, 2014. The Company had outstanding surety bonds of $158,568 as of March 31, 2014.
7. Stockholders' Equity
In January 2014, the Company completed the acquisition of 68% of U.S. Medical Management. and as a result, issued 2,243,217 shares of Centene common stock to the selling stockholders.
8. Earnings (Loss) Per Share
The following table sets forth the calculation of basic and diluted net earnings per common share:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 |
Earnings attributable to Centene Corporation: | | | |
Earnings from continuing operations, net of tax | $ | 33,816 |
| | $ | 22,639 |
|
Discontinued operations, net of tax | (833 | ) | | 363 |
|
Net earnings | $ | 32,983 |
| | $ | 23,002 |
|
| | | |
Shares used in computing per share amounts: | |
| | |
Weighted average number of common shares outstanding | 57,483,876 |
| | 52,357,119 |
|
Common stock equivalents (as determined by applying the treasury stock method) | 1,877,390 |
| | 1,909,809 |
|
Weighted average number of common shares and potential dilutive common shares outstanding | 59,361,266 |
| | 54,266,928 |
|
| | | |
Net earnings (loss) per common share attributable to Centene Corporation: | | | |
Basic: | | | |
Continuing operations | $ | 0.59 |
| | $ | 0.43 |
|
Discontinued operations | (0.02 | ) | | 0.01 |
|
Basic earnings per common share | $ | 0.57 |
| | $ | 0.44 |
|
| | | |
Diluted: | | | |
Continuing operations | $ | 0.57 |
| | $ | 0.41 |
|
Discontinued operations | (0.01 | ) | | 0.01 |
|
Diluted earnings per common share | $ | 0.56 |
| | $ | 0.42 |
|
The calculation of diluted earnings per common share for the three months ended March 31, 2014 and 2013 excludes the impact of 22,956 shares and 23,351 shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.
9. Segment Information
Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene’s health plans including all of the functions needed to operate them. The Specialty Services segment consists of Centene’s specialty companies offering auxiliary healthcare services and products.
Segment information for the three months ended March 31, 2014, follows:
|
| | | | | | | | | | | | | | | |
| Managed Care | | Specialty Services | | Eliminations | | Consolidated Total |
Premium and service revenues from external customers | $ | 2,969,721 |
| | $ | 382,340 |
| | $ | — |
| | $ | 3,352,061 |
|
Premium and service revenues from internal customers | 12,825 |
| | 638,916 |
| | (651,741 | ) | | — |
|
Total premium and service revenues | $ | 2,982,546 |
| | $ | 1,021,256 |
| | $ | (651,741 | ) | | $ | 3,352,061 |
|
Earnings from operations | $ | 44,130 |
| | $ | 25,904 |
| | $ | — |
| | $ | 70,034 |
|
Segment information for the three months ended March 31, 2013, follows:
|
| | | | | | | | | | | | | | | |
| Managed Care | | Specialty Services | | Eliminations | | Consolidated Total |
Premium and service revenues from external customers | $ | 2,296,449 |
| | $ | 125,384 |
| | $ | — |
| | $ | 2,421,833 |
|
Premium and service revenues from internal customers | 10,053 |
| | 527,453 |
| | (537,506 | ) | | — |
|
Total premium and service revenues | $ | 2,306,502 |
| | $ | 652,837 |
| | $ | (537,506 | ) | | $ | 2,421,833 |
|
Earnings from operations | $ | 9,259 |
| | $ | 30,341 |
| | $ | — |
| | $ | 39,600 |
|
10. Contingencies
In October 2012, the Company notified the Kentucky Cabinet for Health and Family Services (Cabinet) that it was exercising a contractual right that it believes allows the Company to terminate its Medicaid managed care contract with the Commonwealth of Kentucky (Commonwealth) effective July 5, 2013. The Company also filed a lawsuit in Franklin Circuit Court against the Commonwealth seeking a declaration of the Company's right to terminate the contract on July 5, 2013. In April 2013, the Commonwealth answered that lawsuit and filed counterclaims against the Company seeking declaratory relief and damages. In May 2013, the Franklin Circuit Court ruled that Kentucky Spirit does not have a contractual right to terminate the contract early. Kentucky Spirit has appealed that ruling to the Kentucky Court of Appeals.
The Company also filed a formal dispute with the Cabinet for damages incurred under the contract, which was later appealed to and denied by the Finance and Administration Cabinet. In response, the Company filed a lawsuit in April 2013, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches. This lawsuit was subsequently consolidated with the original lawsuit for declaratory relief and continues to proceed.
Kentucky Spirit's efforts to resolve issues with the Commonwealth were unsuccessful and on July 5, 2013, Kentucky Spirit proceeded with its previously announced exit. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract. The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's $25,000 performance bond. In March 2014, Kentucky Spirit received a demand letter from the Commonwealth seeking approximately $46,000 to reimburse the Commonwealth for its alleged incurred and expected losses, expenses, transition costs and other damages for the period July 6, 2013 until July 5, 2014. The letter states that the Commonwealth is seeking damages only on behalf of the Commonwealth, not the federal Centers for Medicare and Medicaid Services (CMS). The letter alleges that the total increased costs to the Commonwealth’s Medicaid program due to Kentucky Spirit’s exit is approximately $154,000. Kentucky Spirit disputes the Commonwealth's alleged damages, is pursuing its own litigation claims for damages against the Commonwealth and will vigorously defend against any allegations that it has breached the contract.
The resolution of the Kentucky litigation matters may result in a range of possible outcomes. If the Company prevails on its claims, Kentucky Spirit would be entitled to damages under its lawsuit. If the Commonwealth prevails, a liability to the Commonwealth could be recorded. The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation. As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of March 31, 2014. While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known.
Excluding the Kentucky matters discussed above, the Company is routinely subjected to legal proceedings in the normal course of business. While the ultimate resolution of such matters in the normal course of business is uncertain, the Company does not expect the results of any of these matters individually, or in the aggregate, to have a material effect on its financial position, results of operations or cash flows.
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve both known and unknown risks and uncertainties, including those set forth under Part II, Item 1A. “Risk Factors” of this Form 10-Q.
OVERVIEW
In 2013, we classified the operations for Kentucky Spirit Health Plan (KSHP) as discontinued operations for all periods presented in our consolidated financial statements. The following discussion and analysis, with the exception of cash flow information, is presented in the context of continuing operations unless otherwise identified.
Key financial metrics for the first quarter of 2014 are summarized as follows:
| |
• | Quarter-end at-risk managed care membership of 2,885,700, an increase of 332,300 members, or 13% year over year. |
| |
• | Premium and service revenues of $3.4 billion, representing 38% growth year over year. |
| |
• | Health Benefits Ratio of 89.3%, compared to 90.2% in 2013. |
| |
• | General and Administrative expense ratio of 8.8%, compared to 8.4% in 2013. |
| |
• | Operating cash flow of $252.4 million for the first quarter of 2014. |
| |
• | Diluted earnings per share of $0.57, or $0.79 excluding $0.16 of net cost associated with the health insurer fee and $0.06 of U.S. Medical Management acquisition transaction costs, compared to $0.41 in 2013. |
A reconciliation of our diluted earnings per share from continuing operations for the first quarters of 2014 and 2013 is shown below:
|
| | | | | | | |
| 2014 | | 2013 |
Net earnings per diluted share | $ | 0.57 |
| | $ | 0.41 |
|
Net cost associated with the health insurer fee | 0.16 |
| | — |
|
U.S. Medical Management acquisition transaction costs | 0.06 |
| | — |
|
Total, excluding above items | $ | 0.79 |
| | $ | 0.41 |
|
The following items contributed to our revenue and membership growth over the last year:
| |
• | AcariaHealth. In April 2013, we completed the acquisition of AcariaHealth, a specialty pharmacy company. |
| |
• | California. In November 2013, our California subsidiary, California Health and Wellness Plan (CHWP), began operating under a new contract with the California Department of Health Care Services to serve Medicaid beneficiaries in 18 rural counties under the state's Medi-Cal Managed Care Rural Expansion program and Medi-Cal beneficiaries in Imperial County. In January 2014, CHWP also began serving members under the state's Medicaid expansion program. |
| |
• | Florida. In August 2013, our Florida subsidiary, Sunshine Health, began operating under a contract with the Florida Agency for Health Care Administration to serve members of the Medicaid managed care Long Term Care (LTC) program. Enrollment began in August 2013 and has been implemented by region through March 2014. |
| |
• | Health Insurance Marketplaces (HIM). In January 2014, we began serving members enrolled in Health Insurance Marketplaces in certain regions of 9 states: Arkansas, Florida, Georgia, Indiana, Massachusetts, Mississippi, Ohio, Texas and Washington. |
| |
• | Illinois. In March 2014, our Illinois subsidiary, IlliniCare Health Plan, began operating under a new contract as part of the Illinois Medicare-Medicaid Alignment Initiative serving dual-eligible members in Cook, DuPage, Lake, Kane, Kankakee and Will counties (Greater Chicago region). |
| |
• | Massachusetts. In July 2013, our joint venture subsidiary, Centurion, began operating under a new contract with the Department of Corrections in Massachusetts to provide comprehensive healthcare services to individuals incarcerated in Massachusetts state correctional facilities. Centurion is a joint venture between Centene and MHM Services Inc. In January 2014, our CeltiCare subsidiary began operating under a new contract with the Massachusetts Executive Office of Health and Human Services to participate in the MassHealth CarePlus program in all five regions. |
| |
• | Minnesota. In January 2014, Centurion began operating under a new agreement with the Minnesota Department of Corrections to provide managed healthcare services to offenders in the state's correctional facilities. |
| |
• | New Hampshire. In December 2013, our subsidiary, New Hampshire Healthy Families, began operating under a new contract with the Department of Health and Human Services to serve Medicaid beneficiaries. |
| |
• | Ohio. In July 2013, our Ohio subsidiary, Buckeye Community Health Plan (Buckeye), began operating under a new and expanded contract with Ohio Department of Job and Family Services (ODJFS) to serve Medicaid members statewide through Ohio's three newly aligned regions (West, Central/Southeast, and Northeast). Buckeye also began serving members under the ABD Children program in July 2013. In January 2014, Buckeye also began serving members under the state's Medicaid expansion program. |
| |
• | Tennessee. In September 2013, our joint venture subsidiary, Centurion, began operating under a new contract to provide comprehensive healthcare services to individuals incarcerated in Tennessee state correctional facilities. |
| |
• | U.S. Medical Management. In January 2014, we acquired a majority interest in U.S. Medical Management, LLC, a management services organization and provider of in-home health services for high acuity populations. |
| |
• | Washington. In January 2014, we began serving additional Medicaid members under the state's Medicaid expansion program. |
We expect the following items to contribute to our future growth potential:
| |
• | We expect to realize the full year benefit in 2014 of business commenced during 2013 in California, Florida, Massachusetts, New Hampshire, Ohio, and Tennessee and the acquisition of AcariaHealth as discussed above. |
| |
• | In April 2014, we signed a definitive agreement to purchase a noncontrolling interest in Ribera Salud S.A., a Spanish health management group. Centene will be a joint shareholder with Ribera Salud S.A.'s remaining investor, Banco Sabadell, the fourth largest private bank in Spain. The transaction is expected to close in 2014, subject to closing conditions and regulatory approval. |
| |
• | In February 2014, our Mississippi subsidiary, Magnolia Health Plan, was awarded a statewide managed care contract to continue serving members enrolled in the Mississippi Coordinated Access Network (MississippiCAN) program, as one of two contractors. Under the new contract, Magnolia will continue providing outpatient, behavioral health, pharmacy, vision and dental services, and will also begin providing non-emergency transportation as of July 1, 2014. |
| |
• | In December 2013, we signed a definitive agreement to purchase a majority stake in Fidelis SecureCare of Michigan, Inc. (Fidelis), a subsidiary of Fidelis SeniorCare, Inc. The transaction is expected to close in the fourth quarter of 2014, subject to certain closing conditions including regulatory approvals, and will involve cash purchase price payments contingent on the performance of the plan over the course of 2015. Fidelis was recently selected by the Michigan Department of Community Health to provide integrated healthcare services to members who are dually eligible for Medicare and Medicaid in Macomb and Wayne counties. Enrollment is expected to commence in the fourth quarter of 2014. |
| |
• | In November 2013, our South Carolina subsidiary, Absolute Total Care, was selected by the South Carolina Department of Health and Human Services to serve dual-eligible members as part of the state's pilot program to provide integrated and coordinated care for individuals who are eligible for both Medicare and Medicaid. Operations are expected to commence in the second half of 2014. |
| |
• | In September 2013, the Florida Agency for Health Care Administration provided notice of intent to award a contract to our subsidiary, Sunshine Health, in 9 of 11 regions of the Managed Medical Assistance (MMA) program. The MMA program includes TANF recipients as well as ABD and dual-eligible members. The award is subject to challenge and contract readiness periods, with enrollment expected to begin in the second quarter of 2014 and continue through October 2014. In addition, we were recommended as the sole provider under a contract award for the Child Welfare Specialty Plan (Foster Care), which is expected to commence in the second quarter of 2014. |
| |
• | In September 2013, we were awarded a contract in Texas from the Texas Health and Human Services Commission to expand our operations and serve STAR+PLUS members in two Medicaid Rural Service Areas. Enrollment is expected to begin in the second half of 2014. |
| |
• | In August 2012, we were notified by the ODJFS that Buckeye, our Ohio subsidiary, was selected to serve Medicaid members in a dual-eligible demonstration program in three of Ohio's pre-determined seven regions: Northeast (Cleveland), Northwest (Toledo) and West Central (Dayton). This three-year program, which is part of the state of Ohio's Integrated Care Delivery System (ICDS) expansion, will serve those who have both Medicare and Medicaid eligibility. Enrollment is expected to begin in 2014. |
MEMBERSHIP
From March 31, 2013 to March 31, 2014, we increased our at-risk managed care membership by 332,300, or 13%. The following table sets forth our membership by state for our managed care organizations:
|
| | | | | | | | |
| March 31, 2014 | | December 31, 2013 | | March 31, 2013 |
Arizona | 7,100 |
| | 7,100 |
| | 23,300 |
|
Arkansas | 16,400 |
| | — |
| | — |
|
California | 118,100 |
| | 97,200 |
| | — |
|
Florida | 230,300 |
| | 222,000 |
| | 214,600 |
|
Georgia | 331,400 |
| | 318,700 |
| | 314,000 |
|
Illinois | 22,400 |
| | 22,300 |
| | 18,000 |
|
Indiana | 198,700 |
| | 195,500 |
| | 202,400 |
|
Kansas | 145,000 |
| | 139,900 |
| | 133,700 |
|
Louisiana | 149,800 |
| | 152,300 |
| | 162,900 |
|
Massachusetts | 50,800 |
| | 22,600 |
| | 17,300 |
|
Minnesota | 9,400 |
| | — |
| | — |
|
Mississippi | 85,400 |
| | 78,300 |
| | 77,000 |
|
Missouri | 58,100 |
| | 59,200 |
| | 57,900 |
|
New Hampshire | 37,100 |
| | 33,600 |
| | — |
|
Ohio | 181,800 |
| | 173,200 |
| | 157,700 |
|
South Carolina | 96,300 |
| | 91,900 |
| | 90,100 |
|
Tennessee | 21,100 |
| | 20,700 |
| | — |
|
Texas | 904,000 |
| | 935,100 |
| | 948,400 |
|
Washington | 151,700 |
| | 82,100 |
| | 63,500 |
|
Wisconsin | 70,800 |
| | 71,500 |
| | 72,600 |
|
Total | 2,885,700 |
| | 2,723,200 |
| | 2,553,400 |
|
At March 31, 2014, we served 99,700 Medicaid members in Medicaid expansion programs in California, Massachusetts, Ohio and Washington included in the table above.
The following table sets forth our membership by line of business:
|
| | | | | | | | |
| March 31, 2014 | | December 31, 2013 | | March 31, 2013 |
Medicaid | 2,169,100 |
| | 2,054,700 |
| | 1,951,300 |
|
CHIP & Foster Care | 269,200 |
| | 275,100 |
| | 265,400 |
|
ABD & Medicare | 300,500 |
| | 305,300 |
| | 288,400 |
|
HIM | 39,700 |
| | — |
| | — |
|
Hybrid Programs | 14,400 |
| | 19,000 |
| | 24,600 |
|
LTC | 51,800 |
| | 37,800 |
| | 23,700 |
|
Correctional services | 41,000 |
| | 31,300 |
| | — |
|
Total | 2,885,700 |
| | 2,723,200 |
| | 2,553,400 |
|
The following table identifies our dual eligible membership by line of business. The membership tables above include these members.
|
| | | | | | |
| March 31, 2014 | | December 31, 2013 | | March 31, 2013 |
ABD | 72,800 |
| | 71,700 | | 70,000 |
LTC | 41,300 |
| | 28,800 | | 16,100 |
Medicare | 6,500 |
| | 6,500 | | 5,300 |
Total | 120,600 |
| | 107,000 | | 91,400 |
RESULTS OF OPERATIONS
The following discussion and analysis is based on our consolidated statements of operations, which reflect our results of operations for the three months ended March 31, 2014 and 2013, prepared in accordance with generally accepted accounting principles in the United States.
Summarized comparative financial data for the three months ended March 31, 2014 and 2013 is as follows ($ in millions):
|
| | | | | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 | | % Change 2013-2014 |
Premium | $ | 3,070.9 |
| | $ | 2,388.6 |
| | 28.6 | % |
Service | 281.2 |
| | 33.2 |
| | n.m. |
|
Premium and service revenues | 3,352.1 |
| | 2,421.8 |
| | 38.4 | % |
Premium tax and health insurer fee | 107.8 |
| | 103.7 |
| | 4.0 | % |
Total revenues | 3,459.9 |
| | 2,525.5 |
| | 37.0 | % |
Medical costs | 2,742.5 |
| | 2,154.5 |
| | 27.3 | % |
Cost of services | 242.3 |
| | 25.1 |
| | n.m. |
|
General and administrative expenses | 295.5 |
| | 203.3 |
| | 45.4 | % |
Premium tax expense | 78.3 |
| | 103.0 |
| | (24.0 | )% |
Health insurer fee expense | 31.3 |
| | — |
| | n.m. |
|
Earnings from operations | 70.0 |
| | 39.6 |
| | 76.9 | % |
Investment and other income, net | (2.3 | ) | | (2.4 | ) | | 2.7 | % |
Earnings from continuing operations, before income tax expense | 67.7 |
| | 37.2 |
| | 81.9 | % |
Income tax expense | 34.6 |
| | 14.7 |
| | 135.2 | % |
Earnings from continuing operations, net of income tax | 33.1 |
| | 22.5 |
| | 47.2 | % |
Discontinued operations, net of income tax expense (benefit) of $(0.0) and $0.3 respectively | (0.8 | ) | | 0.4 |
| | (329.5 | )% |
Net earnings | 32.3 |
| | 22.9 |
| | 41.2 | % |
Noncontrolling interest | (0.7 | ) | | (0.1 | ) | | n.m. |
|
Net earnings attributable to Centene Corporation | $ | 33.0 |
| | $ | 23.0 |
| | 43.4 | % |
| | | | | |
Amounts attributable to Centene Corporation common shareholders: |
| | |
Earnings from continuing operations, net of income tax expense | $ | 33.8 |
| | $ | 22.6 |
| | 49.4 | % |
Discontinued operations, net of income tax expense | (0.8 | ) | | 0.4 |
| | (329.5 | )% |
Net earnings | $ | 33.0 |
| | $ | 23.0 |
| | 43.4 | % |
| | | | | |
Diluted earnings per common share attributable to Centene Corporation: |
Continuing operations | $ | 0.57 |
| | $ | 0.41 |
| | 39.0 | % |
Discontinued operations | (0.01 | ) | | 0.01 |
| | (200.0 | )% |
Total diluted earnings per common share | $ | 0.56 |
| | $ | 0.42 |
| | 33.3 | % |
n.m.: not meaningful.
Three Months Ended March 31, 2014 Compared to Three Months Ended March 31, 2013
Premium and Service Revenues
Premium and service revenues increased 38.4% in the three months ended March 31, 2014 over the corresponding period in 2013 primarily as a result of expansions in Florida and Ohio, the additions of the California, New Hampshire and three Centurion contracts, our participation in the Health Insurance Marketplaces, and the acquisitions of AcariaHealth and U.S. Medical Management. During the three months ended March 31, 2014, we received premium rate adjustments which yielded a net (0.1)% composite change across all of our markets.
Operating Expenses
Medical Costs
Results of operations depend on our ability to manage expenses associated with health benefits and to accurately estimate costs incurred. The Health Benefits Ratio, or HBR, represents medical costs as a percentage of premium revenues (excluding Premium Tax and Health Insurer Fee revenues) and reflects the direct relationship between the premium received and the medical services provided. The table below depicts the HBR for our membership by member category for the three months ended March 31,:
|
| | | | | |
| 2014 | | 2013 |
Medicaid, CHIP, Foster Care & HIM | 86.9 | % | | 90.8 | % |
ABD, LTC & Medicare | 92.9 |
| | 90.0 |
|
Specialty Services | 87.7 |
| | 83.4 |
|
Total | 89.3 |
| | 90.2 |
|
The consolidated HBR for the three months ended March 31, 2014, was 89.3%, compared to 90.2% in the same period in 2013. The HBR improvement compared to 2013 reflects a lower level of flu costs compared to prior year and reduced utilization in certain markets in the first quarter of 2014 associated with inclement weather.
Revenue and HBR results for new business and existing business are listed below to assist in understanding our results of operations. Existing businesses are primarily state markets or significant geographic expansion in an existing state or product that we have managed for four complete quarters. New businesses are primarily new state markets or significant geographic expansion in an existing state or product that conversely, we have not managed for four complete quarters. The following table compares the results for new business and existing business for the three months ended March 31,:
|
| | | | | |
| 2014 | | 2013 |
Premium and Service Revenue | | | |
New business | 20 | % | | 37 | % |
Existing business | 80 | % | | 63 | % |
| | | |
HBR | | | |
New business | 93.1 | % | | 93.7 | % |
Existing business | 88.3 | % | | 88.2 | % |
Cost of Services
Cost of services increased by $217.2 million in the three months ended March 31, 2014, compared to the corresponding period in 2013. This was primarily due to the acquisition of AcariaHealth and U.S. Medical Management.
General & Administrative Expenses
General and administrative expenses, or G&A, increased by $92.2 million in the three months ended March 31, 2014, compared to the corresponding period in 2013. This was primarily due to expenses for additional staff and facilities to support our membership growth, the addition of the AcariaHealth business as well as U.S. Medical Management acquisition transaction costs.
The consolidated G&A expense ratio for the three months ended March 31, 2014 and 2013 was 8.8% and 8.4%, respectively. The year over year increase reflects U.S. Medical Management transaction costs and the addition of the AcariaHealth business, partially offset by the leveraging of expenses over higher revenue in 2014.
Health Insurer Fee Expense
During the three months ended March 31, 2014, we recorded $31.3 million of non-deductible expense for the Affordable Care Act (ACA) annual health insurer fee. In addition, we received signed agreements from 13 of 17 applicable states as of March 31, 2014, which provide for the reimbursement of the ACA insurer fee including the related gross-up for the associated income tax effects. As a result, we recorded $29.4 million of revenue in Premium Tax and Health Insurer Fee revenue associated with the accrual for the reimbursement of the fee. The net effect of the health insurer fee reduced our diluted earnings per share by $0.16 during the first quarter of 2014 due to the timing of the recognition of the revenue associated with the reimbursement from our state customers. During the year ended December 31, 2014, we expect to record $125.3 million of non-deductible expense for the health insurer fee expense.
Other Income (Expense)
The following table summarizes the components of other income (expense) for the three months ended March 31, ($ in millions):
|
| | | | | | | |
| 2014 | | 2013 |
Investment income | $ | 4.7 |
| | $ | 4.3 |
|
Interest expense | (7.0 | ) | | (6.6 | ) |
Other income (expense), net | $ | (2.3 | ) | | $ | (2.3 | ) |
The increase in investment income in 2014 reflects an increase in investment balances over 2013. Interest expense increased in 2014 compared to 2013, reflecting increased revolver borrowings.
Income Tax Expense
Excluding the effects of noncontrolling interest, our effective tax rate for the three months ended March 31, 2014 and 2013, was a tax expense of 50.5% and 39.4%, respectively. The increase is due to the non-deductibility of the health insurer fee for income tax purposes. The loss of deduction from the health insurer fee increased our effective tax rate by 960 basis points.
Segment Results
The following table summarizes our consolidated operating results by segment for the three months ended March 31, ($ in millions):
|
| | | | | | | | | | |
| 2014 | | 2013 | | % Change 2013-2014 |
Premium and Service Revenues | | | | | |
Managed Care | $ | 2,982.5 |
| | $ | 2,306.5 |
| | 29.3 | % |
Specialty Services | 1,021.3 |
| | 652.8 |
| | 56.4 | % |
Eliminations | (651.7 | ) | | (537.5 | ) | | 21.3 | % |
Consolidated Total | $ | 3,352.1 |
| | $ | 2,421.8 |
| | 38.4 | % |
Earnings from Operations | |
| | |
| | |
|
Managed Care | $ | 44.1 |
| | $ | 9.3 |
| | 376.6 | % |
Specialty Services | 25.9 |
| | 30.3 |
| | (14.6 | )% |
Consolidated Total | $ | 70.0 |
| | $ | 39.6 |
| | 76.9 | % |
Managed Care
Premium and service revenues increased 29.3% in the three months ended March 31, 2014, primarily as a result of expansions in Florida and Ohio and the additions of the California and New Hampshire contracts. Earnings from operations increased $34.8 million between years primarily reflecting a lower level of flu costs compared to prior year and reduced utilization in certain markets in the first quarter of 2014 associated with inclement weather.
Specialty Services
Premium and service revenues increased 56.4% in the three months ended March 31, 2014, due to the acquisitions of AcariaHealth and U.S. Medical Management, services associated with membership growth in the Medicaid segment, and the addition of three Centurion contracts. Earnings from operations decreased $4.4 million in the three months ended March 31, 2014, reflecting lower margins in our pharmacy business.
LIQUIDITY AND CAPITAL RESOURCES
Shown below is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions).
|
| | | | | | | |
| Three Months Ended March 31, |
| 2014 | | 2013 |
Net cash provided by operating activities | $ | 252.4 |
| | $ | 43.0 |
|
Net cash used in investing activities | (150.5 | ) | | (156.3 | ) |
Net cash provided by financing activities | 130.8 |
| | 0.1 |
|
Net increase (decrease) in cash and cash equivalents | $ | 232.7 |
| | $ | (113.2 | |